StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson rISPERDAL CONSTA (risperidone) [reported separately through FY2022Q4] — U.S. sales ($M) ($M)

Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule

QuarterlyAnnual
Latest, Q4 2022
133
Period ended Jan 1, 2023
Change on a year earlier
-1,208.3%
-12 in Q4 2021
History
25 quarters
Since Q4 2016
Sources
18
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRISPERDAL CONSTA (risperidone) [reported separately through FY2022Q4] — U.S. sales ($M) ($M)Year on yearSource
Q4 2022Jan 1, 2023133-1,208.3%Form 10-K (filed 2024-02-16) ↗
Q3 2022Oct 2, 202267-5.6%Form 10-Q (filed 2022-10-27) ↗
Q2 2022Jul 3, 202265-9.7%Form 10-Q (filed 2022-07-29) ↗
Q1 2022Apr 3, 202263-6.0%Form 10-Q (filed 2022-04-29) ↗
Q4 2021Jan 2, 2022-12-115.8%Form 10-K (filed 2024-02-16) ↗
Q3 2021Oct 3, 202171+1.4%Form 10-Q (filed 2022-10-27) ↗
Q2 2021Jul 4, 202172-2.7%Form 10-Q (filed 2022-07-29) ↗
Q1 2021Apr 4, 202167-11.8%Form 10-Q (filed 2022-04-29) ↗
Q4 2020Jan 3, 202176-1.3%Form 10-K (filed 2023-02-16) ↗
Q3 2020Sep 27, 202070-11.4%Form 10-Q (filed 2021-10-29) ↗
Q2 2020Jun 28, 202074-8.6%Form 10-Q (filed 2021-07-29) ↗
Q1 2020Mar 29, 202076-1.3%Form 10-Q (filed 2021-04-30) ↗
Q4 2019Dec 29, 2019770.0%Form 10-K (filed 2022-02-17) ↗
Q3 2019Sep 29, 201979+3.9%Form 10-Q (filed 2020-10-23) ↗
Q2 2019Jun 30, 201981+1.2%Form 10-Q (filed 2020-07-24) ↗
Q1 2019Mar 31, 201977-6.1%Form 10-Q (filed 2019-05-01) ↗

Breakdown

What makes up risperdal consta (risperidone) [reported separately through fy2022q4] — u.s. sales ($m)

Cite this data

StockData. (2026). Johnson & Johnson RISPERDAL CONSTA (risperidone) [reported separately through FY2022Q4] — U.S. sales ($M) ($M), quarterly Q4 2016–Q4 2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug_risperdal_consta_us

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.